AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PUMA ALPHA VCT PLC

Prospectus Jun 22, 2023

5039_prs_2023-06-22_05efa79a-e363-42ed-ad7d-85159748f993.html

Prospectus

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6185D

Puma Alpha VCT PLC

22 June 2023

Puma Alpha VCT plc

22 June 2023

Issue of Supplementary Prospectus

The Board of Puma Alpha VCT plc (the "Company") announces that it has today published a supplementary prospectus (the "Supplementary Prospectus") relating to the Company's offer for subscription to raise up to £15 million, with an over-allotment facility of up to £5 million (the "Offer"), details of which were set out in a prospectus issued by the Company on 29 November 2022.

The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of The Financial Services and Market Act 2000 following the publication by the Company of its annual report and accounts for the period ended 28 February 2023. Certain information from the annual report and accounts is incorporated by reference into the Supplementary Prospectus.

A copy of the Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

A copy of the Supplementary Prospectus will also be available from the Company's website at:

http://www.pumainvestments.co.uk

For further information please contact:

Paul Frost

Company Secretary

Puma Alpha VCT plc

020 7408 4050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPUUUAROSUNUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.